TBPH
Theravance Biopharma Inc
NASDAQ · Pharmaceuticals
$20.48
+0.90 (+4.60%)
Open$19.57
Previous Close$19.58
Day High$20.49
Day Low$19.00
52W High$21.03
52W Low$7.90
Volume—
Avg Volume376.5K
Market Cap1.04B
P/E Ratio35.37
EPS$0.56
SectorPharmaceuticals
Analyst Ratings
Strong Buy
13 analysts
Price Target
+21.8% upside
Current
$20.48
$20.48
Target
$24.95
$24.95
$16.23
$24.95 avg
$30.59
Key Financials
| FY 2026 | FY 2025 | FY 2025 | |
|---|---|---|---|
| Revenue | 66.79M | 63.49M | 605.82M |
| Net Income | -58,526,658 | -50,070,334 | 94.40M |
| Profit Margin | -87.6% | -83.3% | 15.6% |
| EBITDA | -46,927,738 | -42,377,710 | 130.00M |
| Free Cash Flow | — | — | 125.40M |
| Rev Growth | +5.2% | +5.2% | +6.8% |
| Debt/Equity | 0.17 | 0.17 | 1.28 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,058.18 | +3.66% | 48.5 | 1.00T |
| JNJ | Johnson & Johnson | $239.99 | +0.93% | 21.6 | 578.21B |
| MRK | Merck & Co. Inc. | $121.93 | +1.82% | 16.6 | 302.63B |
| PFE | Pfizer Inc. | $27.22 | +2.76% | 19.9 | 154.76B |
| BMY | Bristol-Myers Squibb Co | $61.99 | +4.15% | 17.9 | 126.20B |
| ZTS | Zoetis Inc | $127.42 | +0.54% | 21.5 | 56.95B |